Cytek Biosciences (CTKB) EPS (Basic) Growth (3y) (2023 - 2026)
Powered by 
Analysis
Cytek Biosciences (CTKB) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.85 Bn | 8.34 Bn | 10.33% |
| 2 | Danaher | 144.67 Bn | 140.33 Bn | 3.61 Bn | -6.31% |
| 3 | Agilent Technologies | 41.02 Bn | 39.26 Bn | 1.04 Bn | 50.37% |
| 4 | Illumina | 31.29 Bn | 30.12 Bn | 770.00 Mn | 43.02% |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | 17.82% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 6.41% |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | 32.96% |
| 8 | Repligen | 9.31 Bn | 8.29 Bn | 110.04 Mn | -37.01% |
| 9 | 10x Genomics | 8.66 Bn | 8.10 Bn | 112.50 Mn | 36.34% |
| 10 | Cytek Biosciences | 610.41 Mn | 536.56 Mn | 28.34 Mn | -42.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.75% |
| Mar 31, 2026 | -42.89% |
| Dec 31, 2025 | -147.45% |
| Sep 30, 2025 | -76.23% |
| Jun 30, 2025 | -114.62% |
| Mar 31, 2025 | -80.56% |
| Sep 30, 2024 | 31.01% |
| Mar 31, 2024 | -154.98% |
| Dec 31, 2023 | 27.25% |
| Sep 30, 2023 | -43.27% |
| Jun 30, 2023 | -35.43% |